Children’s cancer, brain tumors, pancreatic cancer and a range of neurological conditions comprise the diseases targeted by this year’s research projects selected by the Minnesota Partnership for Biotechnology and Medical Genomics. Dr. Edward “Ted” Hinchcliffe leader of the Cellular Dynamics lab at The Hormel Institute UMN in Austin is the lead PI from the UMN (The Hormel Institute), along with collaborators Dr. James Robinson, leader of the Cell Signaling and Tumorigenesis lab (Hormel Institute) and Drs. Jann Sarkaria and David Daniels, both physician/scientists from the Mayo Clinic.

Five competitive grants will help partnering researchers advance early studies in medical science affecting conditions that have statewide impact. Each project, which is a collaborative effort between a University of Minnesota investigator and a Mayo Clinic investigator, will take an approach that could not be pursued by either institution independently.

This is the 17th anniversary for the state-funded awards, which this year provided medical researchers with $4.6 million.